Pages that link to "Q35745831"

The following pages link to DNA vaccines against human immunodeficiency virus type 1 in the past decade (Q35745831):

Displaying 39 items.

• Microbicides: a new hope for HIV prevention (Q27022779) (← links)
• Tetraspanins in viral infections: a fundamental role in viral biology? (Q27470936) (← links)
• Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. (Q27472925) (← links)
• DNA vaccines for HIV: challenges and opportunities. (Q30357322) (← links)
• Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
• Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites (Q33768911) (← links)
• Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 (Q33883887) (← links)
• Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice (Q34100221) (← links)
• Current progress in the development of a prophylactic vaccine for HIV-1. (Q34502108) (← links)
• Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs (Q34831450) (← links)
• Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2 (Q35054374) (← links)
• Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro (Q35160688) (← links)
• Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon (Q35634943) (← links)
• DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection (Q35758746) (← links)
• DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults (Q35940696) (← links)
• Plasmodium inui infection reduces the efficacy of a simian immunodeficiency virus DNA vaccine in a rhesus macaque model through alteration of the vaccine-induced immune response (Q36379235) (← links)
• Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses (Q36571388) (← links)
• Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy (Q36746882) (← links)
• Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine (Q36846517) (← links)
• DNA vaccines against mycobacterial diseases (Q36895737) (← links)
• The potential of topical DNA vaccines adjuvanted by cytokines (Q36960508) (← links)
• Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice (Q37254368) (← links)
• HIV/AIDS vaccines: a need for new concepts? (Q37344236) (← links)
• Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge (Q38443780) (← links)
• Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. (Q38730774) (← links)
• Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa (Q38876358) (← links)
• Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNA (Q39797438) (← links)
• GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model. (Q40173137) (← links)
• Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination (Q40491287) (← links)
• Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus (Q45410977) (← links)
• Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection. (Q45436855) (← links)
• Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery (Q45886136) (← links)
• Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens (Q47790307) (← links)
• A novel recombinant bacterial vaccine strain expressing dual viral antigens induces multiple immune responses to the Gag and gp120 proteins of HIV-1 in immunized mice. (Q50060567) (← links)
• A targeted fimA DNA vaccine prevents alveolar bone loss in mice after intra-nasal administration (Q56898983) (← links)
• DNA vaccines against mycobacterial diseases (Q57203115) (← links)
• Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine (Q79756035) (← links)
• Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination (Q84774654) (← links)
• Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens (Q91677092) (← links)